Skip to main content
. 2017 May 31;42(13):2593–2601. doi: 10.1038/npp.2017.26

Table 2. Main Outcomes of the Study at Different Time Points.

    HDRS
  Baseline Week 1 Week 2 Week 4 Week 6 Week 8
Sham
 PP 25.32 (3.76) 21.83 (6.67) 19.39 (7.42) 18.26 (9.88) 18.56 (10.11) 18.56 (9.64)
 ITT 25.32 (3.76) 22.2 (5.84) 20 (7.5) 18.96 (9.83) 19.24 (10.02) 19.24 (9.59)
             
dTMS
 PP 25.8 (5.25) 20.36 (5.72) 15.56 (8.22) 13.5 (9.41) 13.43 (10.91) 15.95 (11.20)
 ITT 25.8 (5.25) 20.36 (5.72) 15.68 (7.9) 14.08 (8.99) 14.04 (10.13) 16.48 (10.17)
             
Contrast (difference (95% CI); p
 PP 0.48 (−3.97–4.93); p=0.83 −1.61 (−6.09–2.87); p=0.48 −4.18 (−8.74–0.38); p=0.07 −5.03 (−9.62–−0.45); p=0.03 −5.54 (−10.16–−0.92); p=0.01 −2.79 (−7.44–1.85); p=0.23
 ITT 0.48 (−3.96–4.92); p=0.83 −1.84 (−6.28–2.60); p=0.41 −4.32 (−8.76–0.12); p=0.056 −4.88 (−9.32−0.43); p=0.03 −5.2 (−9.64–−0.75); p=0.02 −2.76 (−7.20–1.68); p=0.22

Abbreviations: dTMS, deep transcranial magnetic stimulation; PP, per protocol analyses; ITT, intention to treat analyses.

p values represent results for the mixed model ANOVA time × group interaction (for the main analysis) or time × dTMS (for the factorial analysis) interaction at each week; values in bold represent significant interactions at a p⩽0.05 level.